TY - JOUR
T1 - Improved surgical outcomes for hilar cholangiocarcinoma
T2 - changes in surgical procedures and related outcomes based on 40 years of experience at a single institution
AU - Higuchi, Ryota
AU - Ota, Takehiro
AU - Yazawa, Takehisa
AU - Kajiyama, Hideki
AU - Araida, Tatsuo
AU - Furukawa, Toru
AU - Yoshikawa, Tatsuya
AU - Takasaki, Ken
AU - Yamamoto, Masakazu
N1 - Publisher Copyright:
© 2015, Springer Japan.
PY - 2016/1/1
Y1 - 2016/1/1
N2 - Purpose: This study aimed to examine the changes in procedures for hilar cholangiocarcinoma (HC) surgery and patient survival following HC surgery over a 40-year period. Methods: Between 1974 and 2014, 239 consecutive patients underwent surgery for HC. The changes in perioperative therapy and short- and long-term surgical outcomes were evaluated. Results: The rates of major hepatectomy (in particular, right hepatectomy) and R0 resection significantly increased. Blood loss, transfusion rate, morbidity, and surgical mortality all significantly decreased. The 5-year disease-specific survival was 9.29 % (n = 38) in 1974–1988, 41.1 % (n = 88) in 1989–2003 and 55.6 % (n = 57) in 2004–2008 (p = 0.0001: 1974–1988 vs 1989–2003, p < 0.0001:1974–1988 vs 2004–2008, p = 0.076: 1989–2003 vs 2004–2008). According to a multivariate analysis, Bismuth classification IV (HR vs I, 2.86), period 1989–2003 (HR vs 1974–1988, 0.31), 2004–2008 (HR vs 1974–1988, 0.26), and R1 or R2 resection (HR vs R0, 2.22) were independent prognostic factors. Conclusion: The surgical outcomes for HC over the 40-year period clearly improved as a result of aggressive surgery and progress in surgical techniques, perioperative management, and diagnostic tools.
AB - Purpose: This study aimed to examine the changes in procedures for hilar cholangiocarcinoma (HC) surgery and patient survival following HC surgery over a 40-year period. Methods: Between 1974 and 2014, 239 consecutive patients underwent surgery for HC. The changes in perioperative therapy and short- and long-term surgical outcomes were evaluated. Results: The rates of major hepatectomy (in particular, right hepatectomy) and R0 resection significantly increased. Blood loss, transfusion rate, morbidity, and surgical mortality all significantly decreased. The 5-year disease-specific survival was 9.29 % (n = 38) in 1974–1988, 41.1 % (n = 88) in 1989–2003 and 55.6 % (n = 57) in 2004–2008 (p = 0.0001: 1974–1988 vs 1989–2003, p < 0.0001:1974–1988 vs 2004–2008, p = 0.076: 1989–2003 vs 2004–2008). According to a multivariate analysis, Bismuth classification IV (HR vs I, 2.86), period 1989–2003 (HR vs 1974–1988, 0.31), 2004–2008 (HR vs 1974–1988, 0.26), and R1 or R2 resection (HR vs R0, 2.22) were independent prognostic factors. Conclusion: The surgical outcomes for HC over the 40-year period clearly improved as a result of aggressive surgery and progress in surgical techniques, perioperative management, and diagnostic tools.
KW - Bile duct cancer
KW - Cholangiocarcinoma
KW - Hepatectomy
KW - Hilar
KW - Surgery
KW - Survival
UR - http://www.scopus.com/inward/record.url?scp=84949257200&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84949257200&partnerID=8YFLogxK
U2 - 10.1007/s00595-015-1119-1
DO - 10.1007/s00595-015-1119-1
M3 - Article
AN - SCOPUS:84949257200
SN - 0941-1291
VL - 46
SP - 74
EP - 83
JO - Surgery Today
JF - Surgery Today
IS - 1
ER -